Palisade Capital Management, Lp
Source: SEC Form 13F · as of Mar 2026Palisade Capital Management, Lp holds 4 biotech & pharma companies tracked by BioSniper, totaling $16.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$16.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Axsome Therapeutics, Inc. (AXSM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| AXSMAxsome Therapeutics, Inc. | 40,563 | $6.9M |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 6,140,639 | $4.9M |
| LGNDLigand Pharmaceuticals Incorporated | 20,525 | $4.1M |
| GILDGILEAD SCIENCES, INC. | 2,742 | $382K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.